Tinambing, Jessa .
HRN: 29-08-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2026
AMPICILLIN 1GM (VIAL)
06/01/2026
06/08/2026
IV
2g
Q6
PROM
Checking Initial Appropriateness
06/02/2026
CEFAZOLIN 1GM (VIAL)
06/02/2026
06/02/2026
IVT
2g
SD
CS
Checking Initial Appropriateness
06/02/2026
CEFAZOLIN 1GM (VIAL)
06/02/2026
06/05/2026
IV
1 Gram
Q8h
CS
Checking Initial Appropriateness